Get started
Author

RK Murthy

Observed names: R Murthy, R.K. Murthy
Observed institutions: Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of Louisville, University of California, Los Angeles, Peter MacCallum Cancer Centre, Yale Cancer Center, Dana-Farber Cancer Institute, Aichi Cancer Center, University of Colorado Cancer Center, Tennessee Oncology, The Cancer Institute Hospital, National Cancer Center Hospital East, Dana-Farber Brigham Cancer Center, Japanese Foundation For Cancer Research, Moores Cancer Center, Vanderbilt-Ingram Cancer Center, Winship Cancer Institute, National Cancer Center Hospital, Charité - Universitätsmedizin Berlin, Kindai University
OpenAlex ID: A5048349889
Abstract P6-17-02: Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study
2019 · S Modi, J Tsurutani, et al. · Cancer Research · 27
293P Impact of tucatinib on progression free survival in patients with HER2+ metastatic breast cancer and stable or active brain metastases
2020 · T. Bachelot, N.U. Lin, et al. · Annals of Oncology · 9
Abstract P3-14-02: Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer (TNBC): Evidence of efficacy and proof of concept from a phase I trial with dose expansion of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab
2016 · RK Basho, M Gilcrease, et al. · Cancer Research · 4
Abstract P6-17-04: 3-year relapse-free survival of stage II-III HER2-neu positive breast cancer treated with pertuzumab and trastuzumab-containing neoadjuvant therapy compared to trastuzumab-containing therapy
2019 · RK Murthy, AS Raghavendra, et al. · Cancer Research
Abstract P1-15-06: Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy
2019 · C Yam, A Raghavendra, et al. · Cancer Research
Abstract OT2-07-08: Withdrawn
2019 · E Paplomata, V Borges, et al. · Cancer Research
Abstract P6-09-23: SETER/PR - A robust 18-gene predictor of sensitivity to endocrine therapy in metastatic breast cancer
2017 · BV Sinn, T-H Tsai, et al. · Cancer Research
Leberfibrose und portale Hypertension induziert durch 90Yttrium Radioembolisation
2008 · TF Jakobs, S Saleem, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Works count: 8
Citation count: 40
H-index: 3
I10-index: 1
Year
Topic
Type